Brevan Howard Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.09M	Buy	33,544 +28,015	+507%	+$4.25M	0.03%	304
2025 Q1	$832K	Sell	5,529 -2,479	-31%	-$373K	0.01%	517
2024 Q4	$1.48M	Buy	8,008 +3,794	+90%	+$700K	0.01%	316
2024 Q3	$830K	Buy	4,214 +1,465	+53%	+$289K	0.01%	458
2024 Q2	$568K	Buy	+2,749	New	+$568K	0.01%	511